Alphabet Inc
DBTX

Alphabet Inc’s Decibel Therapeutics, Inc. Common Stock DBTX Stock Holding History

Alphabet Inc’s Portfolio DBTX Stock Details DBTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,636,258
Closed -$6.3M – 49
2023
Q2 		$6.3M Hold
1,636,258
– – 0.34% 22
2023
Q1 		$4.94M Hold
1,636,258
– – 0.27% 26
2022
Q4 		$3.35M Hold
1,636,258
– – 0.19% 29
2022
Q3 		$5.66M Hold
1,636,258
– – 0.29% 27
2022
Q2 		$6.89M Hold
1,636,258
– – 0.37% 28
2022
Q1 		$4.97M Hold
1,636,258
– – 0.16% 39
2021
Q4 		$7.61M Hold
1,636,258
– – 0.18% 37
2021
Q3 		$12.6M Hold
1,636,258
– – 0.3% 27
2021
Q2 		$14.1M Hold
1,636,258
– – 0.29% 23
2021
Q1 		$18.6M Buy
+1,636,258
New +$25.7M 0.75% 16

Other funds holding DBTX

ACA
Atlas Capital Advisors Jackson, Wyoming $914M AUM

Alphabet Inc's DBTX Position: Q3 2023 in Review

Alphabet Inc sold out of Decibel Therapeutics, Inc. Common Stock (DBTX) in Q3 2023, closing a stake of 1,636,258 shares — an estimated $6.3M sold.

Alphabet Inc first reported a position in DBTX in Q1 2021 and held it in 10 quarters. The position peaked at $18.6M in Q1 2021. 1 fund tracked by Wall St. Rank holds DBTX as of Q3 2023.

  • Alphabet Inc reported no remaining Decibel Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Alphabet Inc sold 1,636,258 Decibel Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $6.3M.
  • Alphabet Inc first reported a position in Decibel Therapeutics, Inc. Common Stock in Q1 2021 and held it in 10 quarters.
  • Alphabet Inc's Decibel Therapeutics, Inc. Common Stock position peaked at $18.6M in Q1 2021.
  • 1 fund tracked by Wall St. Rank held Decibel Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Alphabet Inc's 13F filing for Q3 2023, filed 13 Nov 2023.